Department of Medicine, Graduate School Yonsei University, Seoul, Republic of Korea
Department of Internal Medicine, Division of Endocrinology and Metabolism, Yonsei University College of Medicine, Seoul, Republic of Korea
Brain Korea 21 for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea
Correspondence
Corresponding author. Address: Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea. Fax: +82 2 393 6884.
Department of Medicine, Graduate School Yonsei University, Seoul, Republic of Korea
Department of Internal Medicine, Division of Endocrinology and Metabolism, Yonsei University College of Medicine, Seoul, Republic of Korea
Brain Korea 21 for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea
Correspondence
Corresponding author. Address: Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea. Fax: +82 2 393 6884.
To view the full text, please login as a subscribed user or purchase a subscription.
Click here to view the full text on ScienceDirect.
Abstract
Objective
Atherosclerosis in patients with type 2 diabetes has been linked to oxidative stress. NADP[1]:quinone oxidoreductase 1 (NQO1) plays a key role in cellular antioxidant defense. Recent reports suggest that highly expressed and inducible endogenous NQO1 from cardiovascular cells may act as a potential superoxide scavenger. We examined the relationship between the risk of NQO1 C609T polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
Methods
We recruited 601 (Seoul set) and 233 (Koyang set) unrelated patients with type 2 diabetes from independent groups. The C609T variant of NQO1 was genotyped by Taqman RT-PCR. Mean and maximum carotid intima-media thickness (IMT) and carotid artery plaques were measured by high-resolution ultrasonography.
Results
Patients with the T allele exhibited a higher prevalence of atherosclerotic plaques than non-T allele carriers in both sets (Seoul set vs. Koyang set, p = 0.021, p = 0.023, respectively). After adjusting for age, sex, duration of diabetes, systolic blood pressure, body mass index, current smoking, HDL-cholesterol, LDL-cholesterol and HbA1c, subjects with the T allele had a significantly higher risk of carotid artery plaques (Seoul set vs. Koyang set, OR = 1.65, p = 0.015; OR = 2.00, p = 0.037, respectively) than subjects with the CC genotype.
Conclusion
These results suggest that the C609T polymorphism of NQO1 is associated with carotid artery plaques in type 2 diabetic patients.
